These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8258993)

  • 41. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
    Kum WW; Chow AW
    J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Major histocompatibility complex class I molecule serves as a ligand for presentation of the superantigen staphylococcal enterotoxin B to T cells.
    Häffner AC; Zepter K; Elmets CA
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3037-42. PubMed ID: 8610164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and in-vitro bioactivity of a novel superantigen conjugate targeting bladder carcinoma.
    Zhen G; Cong-hui H; Lin H; Jian-jun Y; Wen-hao T; Gao-jun T
    J Pharm Pharmacol; 2009 Jul; 61(7):869-75. PubMed ID: 19589228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.
    Giantonio BJ; Alpaugh RK; Schultz J; McAleer C; Newton DW; Shannon B; Guedez Y; Kotb M; Vitek L; Persson R; Gunnarsson PO; Kalland T; Dohlsten M; Persson B; Weiner LM
    J Clin Oncol; 1997 May; 15(5):1994-2007. PubMed ID: 9164211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
    Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
    Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
    Ijichi S; Yamano Y; Osame M; Hall WW
    Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antagonistic effects of the staphylococcal enterotoxin a mutant, SEA(F47A/D227A), on psoriasis in the SCID-hu xenogeneic transplantation model.
    Boehncke WH; Hardt-Weinelt K; Nilsson H; Wolter M; Dohlsten M; Ochsendorf FR; Kaufmann R; Antonsson P
    J Invest Dermatol; 2001 Apr; 116(4):596-601. PubMed ID: 11286628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules.
    Rich RR; Mollick JA; Cook RG
    Trans Am Clin Climatol Assoc; 1990; 101():195-204; discussion 204-6. PubMed ID: 2577245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Naptumomab estafenatox, an engineered antibody-superantigen fusion protein with low toxicity and reduced antigenicity.
    Forsberg G; Skartved NJ; Wallén-Ohman M; Nyhlén HC; Behm K; Hedlund G; Nederman T
    J Immunother; 2010 Jun; 33(5):492-9. PubMed ID: 20463598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell adhesion molecules are co-receptors for staphylococcal enterotoxin B-induced T-cell activation and cytokine production.
    Krakauer T
    Immunol Lett; 1994 Feb; 39(2):121-5. PubMed ID: 8013959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK; Leytze G; Klussman K; Ledbetter JA
    Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.
    Inoue M; Plautz GE; Shu S
    Cancer Res; 1996 Oct; 56(20):4702-8. PubMed ID: 8840987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeated treatment with S. aureus superantigens expands the survival rate of Ehrlich ascites tumor bearing mice.
    Mondal TK; Bhatta D; Biswas S; Pal P
    Immunol Invest; 2002 Feb; 31(1):13-28. PubMed ID: 11990460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effective adoptive immunotherapy by T-LAK cells retargeted with bacterial superantigen-conjugated antibody to MUC1 in xenografted severe combined immunodeficient mice.
    Shinoda M; Kudo T; Suzuki M; Katayose Y; Sakurai N; Saeki H; Kodama H; Fukuhara K; Imai K; Hinoda Y; Matsuno S
    Cancer Res; 1998 Jul; 58(13):2838-43. PubMed ID: 9661899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of human vascular endothelial cells by IFN-gamma: acquisition of HLA class II expression, TSST-1-binding activity and accessory activity in T cell activation by the toxin.
    Araake M; Uchiyama T; Imanishi K; Yan XJ
    Int Arch Allergy Appl Immunol; 1991; 96(1):55-61. PubMed ID: 1752697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Naptumomab estafenatox: targeted immunotherapy with a novel immunotoxin.
    Eisen T; Hedlund G; Forsberg G; Hawkins R
    Curr Oncol Rep; 2014 Feb; 16(2):370. PubMed ID: 24445502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses.
    Bhardwaj N; Young JW; Nisanian AJ; Baggers J; Steinman RM
    J Exp Med; 1993 Aug; 178(2):633-42. PubMed ID: 8340760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A.
    Bavari S; Dyas B; Ulrich RG
    J Infect Dis; 1996 Aug; 174(2):338-45. PubMed ID: 8699064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Engagement of major histocompatibility complex class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes.
    Mourad W; Mehindate K; Schall TJ; McColl SR
    J Exp Med; 1992 Feb; 175(2):613-6. PubMed ID: 1732419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA; Shah V; Klein N; Dillon MJ
    Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.